Results 211 to 220 of about 78,970 (275)

Seasonal influenza mRNA vaccine induces stronger innate and comparable or better adaptive responses than licensed inactivated vaccines. [PDF]

NPJ Vaccines
Bermúdez-Méndez E, Lenart K, Arcoverde Cerveira R, Engstrand O, Hellgren F, Cagigi A, Ols S, Jasny E, Reinhardt A, Petsch B, Loré K.   +10 more
europepmc   +1 more source

Characterization and immunogenicity of nanoparticle vaccines displaying embecovirus spike proteins

Biotechnology Progress, EarlyView.
Virus‐like particle vaccines displaying spike proteins from OC43, HKU1 A, and HKU1 B were evaluated in mice for their ability to elicit antibodies against the spike proteins from OC43, HKU1 A, HKU1 B, and HKU1 C. Abstract Endemic human coronaviruses OC43 and HKU1 cause widespread respiratory infections and can be associated with severe illness in ...
Peter J. Halfmann, Augustine Duffy, Alex Wee, Noah Anderson, Jackson Terrell, Yoshihiro Kawaoka, Ravi S. Kane   +6 more
wiley   +1 more source

Immune Protection Effect of an OmpC-Recombinant T4 Bacteriophage Vaccine Against Infection Caused by Extraintestinal Pathogenic <i>Escherichia coli</i> in Mice. [PDF]

Vaccines (Basel)
Zong X, Ni S, Chen G, Li X, Liu J, Tong Z, Yuan Z, Jiang S, Chen H, Tan C, Wang C.   +10 more
europepmc   +1 more source

In‐line Raman spectroscopy real‐time glucose prediction method for commercial pneumococcal vaccine drug substance fermentation manufacturing process control

Biotechnology Progress, EarlyView.
Abstract Traditional off‐line analysis methods to quantify residual metabolite concentrations in a drug substance fermentation process consume valuable time, require costly resources, and demand potentially hazardous manual operations when working with pathogenic biological organisms.
Griffin P. Thomas, Brian C. Marks, Barbara B. Alvarado‐Hernandez, Matthew Woodling, James O'Connor, Roberto Ortiz, John Higgins, Jon Shanter   +7 more
wiley   +1 more source

Harnessing <i>Toxoplasma gondii</i> microneme proteins for serodiagnosis and vaccine development: a review. [PDF]

Ann Med
Ji Y, Wang Z, Feng Y, Ahmad I, Alzahrani KJ, Alsharif KF, Alzahrani FM, Zhao X, Qadeer A, Liu W.   +9 more
europepmc   +1 more source

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

ChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

A novel chicken infectious anemia virus vaccine candidate: complete attenuation, strong immunogenicity, and a built-in DIVA marker. [PDF]

Poult Sci
Song H, Kim H, Her M, Kim H.
europepmc   +1 more source

Living Microbial Drugs

Chemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik, Nazlıcan Tunç, Senem Şen, Urartu Özgür Şafak Şeker   +3 more
wiley   +1 more source

Integrated single-cell and functional analyses define strategies to enhance dendritic cell immunostimulatory capacity. [PDF]

Discov Oncol
Li Y, Li H, Li C, Liu R, Ye S, Li J, Zhao C, Ma X, Cheng X, Xu J.   +9 more
europepmc   +1 more source